Nephrocare Health Services Ltd

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has received a tax demand from the Tashkent City Tax Department, Uzbekistan, for an additional tax assessment of approximately ₹16.50 crore and a financial penalty of approximately ₹3.29 crore. The company believes that the order should be set-aside/quashed and does not have a material adverse impact on its financial position, operations, or business.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd announced Q1 FY27 earnings conference call transcript, with revenues growing 20% YoY, driven by platform business strength, disciplined execution, and patient trust. Management emphasized quality, accessibility, and affordability pillars for dialysis services.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd's overseas step-down subsidiary, Nephrocare Health Care Services, Philippines Inc., has acquired a dialysis center in the Philippines for PhP 75,000,000 (approximately INR 1.4 crore) through an Asset Transfer Agreement.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has declared the voting results along with the scrutinizer's report of the 17th AGM. The meeting was held on August 12, 2026, and the voting results were announced on August 13, 2026. The company has passed six resolutions, including the audited standalone and consolidated financial statements, and the re-appointment of Mr. Gaurav Sharma as a nominee director.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has scheduled an investor conference call on August 18, 2026, to discuss publicly available information.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd's overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement with Juan Nephro Dialysis Center for the acquisition of dialysis center assets in the Philippines for a total consideration of PhP 71,800,000.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd clarifies its earlier disclosure regarding the incorporation of Nephrocare Services Kazakhstan LLP, stating that it is a step-down subsidiary rather than a step-down wholly owned subsidiary.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd held its 17th Annual General Meeting (AGM) on August 12, 2026, through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The meeting was attended by 74 members, and the quorum was present. The Chairman, Mr. Vikram Vuppala, welcomed the members and briefed them about the process to participate in the meeting. The meeting transacted the following items: adoption of the Statutory Auditor's Report, appointment of Mr. Om Prakash Manchanda as Chairman for Item Nos. 5 and 6, and approval of the resolutions set out in the Notice of the AGM.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has uploaded the audio recording of its Q1FY27 financial results conference call on its website.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations, detailing the utilization of proceeds from its Initial Public Offer (IPO). The report, issued by Crisil Ratings Limited, indicates that there were no deviations from the objects of the issue. The report is available on the company's website.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has announced the outcome of its Board meeting held on August 11, 2026, where the Board considered and approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, and reconstituted the Audit Committee and Stakeholders Relationship Committee. The company also announced an internal restructuring of its overseas holding structure, transferring 51% shareholding of Nephrocare Health Services Saudi Arabia Company to NephroPlus Kidney Services Company.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd, Asia's largest dialysis network under the brand 'NephroPlus', announced its Financial Results for first quarter ended June 30, 2026, with revenue of ₹ 281.8 crore, an increase of 23.7% YoY; driven by steady volume growth with treatments up 13.3% YoY to 10.31 lakh and guests up 13.0% YoY to 38,262, alongside an 9.2% YoY improvement in revenue per treatment to ₹2,733.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has released an investor presentation for the quarter ended June 30, 2026, providing unaudited standalone and consolidated financial results.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has announced its un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has also reconstituted its Audit Committee and Stakeholders Relationship Committee. Additionally, it has proposed the transfer of 51% shareholding in Nephrocare Health Services Saudi Arabia Company to NephroPlus Kidney Services Company as part of an internal restructuring.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has scheduled an Investor Conference Call as per the disclosure enclosed herewith, pursuant to Regulation 30 of SEBI Listing Regulations.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has submitted a trading plan under SEBI (Prohibition of Insider Trading) Regulations, 2015, for the sale of 130,000 equity shares between December 7, 2026, and December 11, 2026, with a price limit of Rs. 700.00 per equity share.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has scheduled an Investor Result Conference Call on August 12, 2026, to discuss its Q1FY27 financial results.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11-08-2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd's overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has acquired identified assets relating to a dialysis center in Ipil, Zamboanga Sibugay, Philippines. The acquisition was made through an Asset Transfer Agreement dated June 22, 2026, with Pag-Asa Dialysis And Diagnostic Center, for a total consideration of PhP 80,640,000. This strategic move expands the company's operational footprint in the international market.

Nephrocare Health Services Ltd

Nephrocare Health Services Ltd's board approved the NephroPlus Employee Stock Option Scheme 2026, contemplating the grant of up to 20,06,814 equity shares, representing about 2% of current paid-up capital, subject to shareholder approval. Concurrently, the company approved providing collateral/security support of up to INR 70 Crore to NephroPlus Kidney Services Company, its overseas step-down wholly-owned subsidiary in Saudi Arabia. This support aims to enable the subsidiary to avail credit facilities, superseding a prior approval for a joint venture due to a revised operating structure in Saudi Arabia.